Oral surgery, oral medicine, oral pathology and oral radiology · 2026
Development and validation of a nomogram integrating exfoliative cell DNA ploidy and inflammatory-nutritional markers for the prediction of high-grade dysplasia in oral leukoplakia: a cross-sectional diagnostic study.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Caiyun, Wang Hongtao, Li Yulan, Liu Xiaoqing
Аннотация
OBJECTIVE: To develop a noninvasive nomogram combining exfoliative cell DNA ploidy and systemic inflammatory-nutritional markers for high-grade dysplasia (HGD) prediction in oral leukoplakia (OLK).
STUDY DESIGN: This retrospective diagnostic study included 228 OLK patients. All underwent brush biopsy for DNA image cytometry and blood tests prior to surgical biopsy. Reference standard was histopathology. LASSO and multivariable logistic regression identified predictors for nomogram construction. Performance was evaluated via AUC, calibration, and decision curve analysis.
RESULTS: Of 228 patients, 65 (28.5%) had HGD. DNA aneuploidy (76.9% vs 12.3%, P < .001) and lower Prognostic Nutritional Index (PNI) were independently associated with HGD. The nomogram incorporated DNA ploidy, PNI, clinical type, and smoking history, yielding an AUC of 0.912 in the training set and 0.895 in the validation set, providing significant clinical net benefit.
CONCLUSIONS: Integrating "Локально" DNA ploidy and "systemic" PNI accurately stratifies HGD risk in OLK. This practical tool guides biopsy decision-making and personalizes surveillance strategies.
STUDY DESIGN: This retrospective diagnostic study included 228 OLK patients. All underwent brush biopsy for DNA image cytometry and blood tests prior to surgical biopsy. Reference standard was histopathology. LASSO and multivariable logistic regression identified predictors for nomogram construction. Performance was evaluated via AUC, calibration, and decision curve analysis.
RESULTS: Of 228 patients, 65 (28.5%) had HGD. DNA aneuploidy (76.9% vs 12.3%, P < .001) and lower Prognostic Nutritional Index (PNI) were independently associated with HGD. The nomogram incorporated DNA ploidy, PNI, clinical type, and smoking history, yielding an AUC of 0.912 in the training set and 0.895 in the validation set, providing significant clinical net benefit.
CONCLUSIONS: Integrating "Локально" DNA ploidy and "systemic" PNI accurately stratifies HGD risk in OLK. This practical tool guides biopsy decision-making and personalizes surveillance strategies.